FORGEN`s theme in FOREN I (financing period 1996-1999) and FORGEN II (financing period 1999-2002) is to support application orientated research projects in gene technology which show the promise of potential economic benefits. Through close collaborations with genetic engineering business enterprises, the proccess of converting scientific discoveries into marketable products will be accelerated. The research topics focus on selected new fields of research derived from biomedical research and its application. Using genetic engineering methods, FORGEN is not only involved in developing or improving proceedures for the production of new safe live vaccines, but also in improving various gene vector systems for the transfer of genetic information into body cells (somatic gene therapy) and examining their clinical suitability. A further concern of the "Forschungsverbund" is to publicize information about current research projects, and in particular to enlighten the general public on the subject of gene technology and its applications through organizing or participating in exhibitions and other public relations events.